{"id":24163,"date":"2024-01-08T16:11:30","date_gmt":"2024-01-08T15:11:30","guid":{"rendered":"https:\/\/www.izb-online.de\/unternehmen\/galimedix-therapeutics-gmbh\/"},"modified":"2024-01-08T16:16:42","modified_gmt":"2024-01-08T15:16:42","slug":"galimedix-therapeutics-gmbh","status":"publish","type":"gco_companies","link":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/","title":{"rendered":"Galimedix Therapeutics GmbH"},"content":{"rendered":"

[vc_row][vc_column][\/vc_column][\/vc_row][vc_row el_class=”container-inner”][vc_column][vc_row_inner][vc_column_inner el_class=”gco-tmpl-company__image-column” width=”1\/2″ offset=”vc_col-lg-4 vc_col-md-4″][vc_single_image image=”24160″ img_size=”full” el_class=”gco-tmpl-company__image”][vc_column_text el_class=”gco-tmpl-company__image-info-copyright”] Galimedix Therapeutics GmbH[\/vc_column_text][vc_column_text el_class=”gco-tmpl-company__image-info-desc”]Dr. Alexander Gebauer, Co-founder and Executive Chairman[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/2″ offset=”vc_col-lg-8 vc_col-md-8″][vc_column_text el_class=”gco-company-post-heading”]<\/p>\n

About Galimedix Therapeutics<\/h3>\n

[\/vc_column_text][vc_column_text]Galimedix is a Phase 2 clinical-stage private company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious eye and brain diseases. Founded by a seasoned and highly dedicated team of experts, Galimedix\u2019s groundbreaking small molecules offer the hope of changing the course of disease where amyloid beta (A\u03b2) plays a role, such as in dry age-related macular degeneration (AMD), glaucoma and Alzheimer\u2019s disease – Galimedix\u2019s initial areas of focus. Compelling pre-clinical data support the potential of Galimedix\u2019s product candidates to slow or stop neurodegeneration and also restore lost neuronal function. A Phase 2 proof-of-concept study in dry AMD with lead program, topical GAL-101, is in preparation with strong support from partner, Th\u00e9a Open Innovation (TOI). Clinical studies in other indications are planned. Galimedix\u2019s success was facilitated by seed funding from InFocus Capital Partners and Rimonci Capital, two VC investors highly specialized in vision science technologies.[\/vc_column_text][vc_column_text el_class=”gco-company-post-heading”]<\/p>\n

\n
\n
\n
\n

What is your motivation?<\/h3>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_column_text]<\/p>\n

\n
\n
\n
\n

At Galimedix, we aim to stop neurodegeneration at its source and develop game-changing neuroprotective therapies for the treatment of serious eye and brain diseases impacting millions of people.<\/p>\n

Normal amyloid beta (A\u03b2) monomers are important to neuronal function, but misfolding of these monomers can lead to the development of toxic forms of A\u03b2 \u2013 oligomers and protofibrils –\u00a0that can be highly damaging to the retina and brain cells, and, according to a large number of studies, the underlying cause of neurodegenerative diseases of the eye, such as dry age-related macular degeneration (dAMD), glaucoma. Recent approvals and Phase 3 results of anti-A\u03b2 drugs also have validated them as a key target in Alzheimer\u2019s disease.<\/p>\n

To tackle this, we are developing orally and topically administered small molecules that target the beginning of the A\u03b2 peptide aggregation cascade and, prevent the formation of the toxic species. GAL-101\/201 have a unique mode of action, through which they only remove already formed toxic species, potentially impacting disease progression without disturbing normal neuronal function.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/2″ offset=”vc_col-lg-4 vc_col-md-4″][\/vc_column][vc_column width=”1\/2″ el_class=”gco-tmpl-company-quote” offset=”vc_col-lg-8 vc_col-md-8″][vc_column_text el_class=”gco-tmpl-company-quote__text”]”We are thrilled to move into the IZB in Munich. Stepping into one of Europe\u2019s most vibrant life science hubs, will enable us access to world-class scientists and thriving biotech companies, a perfect environment to move Galimedix into its next stage of development.”[\/vc_column_text][vc_column_text el_class=”gco-tmpl-company-quote__source”]Dr. Alexander Gebauer, Co-founder and Executive Chairman[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"featured_media":24162,"template":"","meta":{"_links_to":"","_links_to_target":""},"company-categories":[205],"class_list":["post-24163","gco_companies","type-gco_companies","status-publish","has-post-thumbnail","hentry","company-categories-startups-en"],"yoast_head":"\nGalimedix Therapeutics GmbH - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Galimedix Therapeutics GmbH\" \/>\n<meta property=\"og:description\" content=\"Galimedix Therapeutics GmbHDr. Alexander Gebauer, Co-founder and Executive Chairman About Galimedix Therapeutics Galimedix is a Phase 2 clinical-stage\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-08T15:16:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2024\/01\/Galimedix-Logo_positiv_RGB.png\" \/>\n\t<meta property=\"og:image:width\" content=\"676\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/galimedix-therapeutics-gmbh\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/galimedix-therapeutics-gmbh\\\/\",\"name\":\"Galimedix Therapeutics GmbH - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/galimedix-therapeutics-gmbh\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/galimedix-therapeutics-gmbh\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Galimedix-Logo_positiv_RGB.png\",\"datePublished\":\"2024-01-08T15:11:30+00:00\",\"dateModified\":\"2024-01-08T15:16:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/galimedix-therapeutics-gmbh\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/galimedix-therapeutics-gmbh\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/galimedix-therapeutics-gmbh\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Galimedix-Logo_positiv_RGB.png\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Galimedix-Logo_positiv_RGB.png\",\"width\":676,\"height\":200,\"caption\":\"Galimedix Therapeutics GmbH\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/galimedix-therapeutics-gmbh\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Startups im IZB\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/company-categories\\\/startups-en\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Galimedix Therapeutics GmbH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Galimedix Therapeutics GmbH - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/","og_locale":"en_US","og_type":"article","og_title":"Galimedix Therapeutics GmbH","og_description":"Galimedix Therapeutics GmbHDr. Alexander Gebauer, Co-founder and Executive Chairman About Galimedix Therapeutics Galimedix is a Phase 2 clinical-stage","og_url":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_modified_time":"2024-01-08T15:16:42+00:00","og_image":[{"width":676,"height":200,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2024\/01\/Galimedix-Logo_positiv_RGB.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/","url":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/","name":"Galimedix Therapeutics GmbH - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2024\/01\/Galimedix-Logo_positiv_RGB.png","datePublished":"2024-01-08T15:11:30+00:00","dateModified":"2024-01-08T15:16:42+00:00","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2024\/01\/Galimedix-Logo_positiv_RGB.png","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2024\/01\/Galimedix-Logo_positiv_RGB.png","width":676,"height":200,"caption":"Galimedix Therapeutics GmbH"},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/galimedix-therapeutics-gmbh\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"Startups im IZB","item":"https:\/\/www.izb-online.de\/en\/company-categories\/startups-en\/"},{"@type":"ListItem","position":3,"name":"Galimedix Therapeutics GmbH"}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}}]}},"gco_companies_contact_fax":"","gco_companies_contact_fon":"","gco_companies_contact_email":"info@galimedix.com","gco_companies_contact_website_url":"www.galimedix.com","gco_companies_contact_website_link_text":"www.galimedix.com","gco_companies_contact_street":"Am Klopferspitz 19","gco_companies_contact_zip":"82152","gco_companies_contact_city":"Planegg\/Martinsried","gco_companies_contact_country":"Germany","gco_companies_info_business_area":"Drug Discovery \/ Drug Development","_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_companies\/24163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_companies"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/gco_companies"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/24162"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=24163"}],"wp:term":[{"taxonomy":"company-categories","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/company-categories?post=24163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}